Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · UnitedHealth (UNH)

UnitedHealth Q1 revenue rises 2% to $111.7 billion; full-year EPS outlook raised

Positive Impact 4 of 5 earnings Written later

UnitedHealth reported first quarter 2026 revenue of $111.7 billion, up from $109.6 billion a year earlier, and GAAP earnings of $6.90 per share, up from $6.85. The company raised its full-year 2026 earnings outlook to greater than $17.35 per share on a GAAP basis and greater than $18.25 per share on an adjusted basis. Earnings from operations were $9.0 billion, slightly below $9.1 billion a year earlier.

Key points

  • Q1 2026 revenue was $111.7 billion, up from $109.6 billion in Q1 2025; GAAP EPS was $6.90 versus $6.85, and adjusted EPS was $7.23 versus $7.20.
  • Full-year 2026 outlook raised to greater than $17.35 per share GAAP and greater than $18.25 per share adjusted.
  • Medical care ratio improved to 83.9% from 84.8%, while the operating cost ratio rose to 13.8% from 12.4%.
  • The company expects to repurchase at least $2.0 billion of its common stock by the end of the second quarter 2026 and has agreed to acquire Alegeus Technologies.

The filing

CompanyUnitedHealth (UNH)
Form8-K, current report
Filed with the SECApr 21, 2026, 6:02 AM ET
Accession number0000731766-26-000121

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.